Valproic acid: reducing the risks of prenatal exposure
- PMID: 26655850
- PMCID: PMC6350527
- DOI: 10.1016/S1474-4422(15)00357-9
Valproic acid: reducing the risks of prenatal exposure
Comment on
-
Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.Lancet Neurol. 2016 Feb;15(2):210-218. doi: 10.1016/S1474-4422(15)00314-2. Epub 2015 Dec 5. Lancet Neurol. 2016. PMID: 26655849 Review.
References
-
- European Medicines Agency. Assessment report. Procedure under article 31 of directive 2001/83/EC resulting from pharmacovigilance data. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/...(accessed Nov 14, 2015).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources